Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results